US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

68.75

+2.924.44%

Post-market: 68.810.0611+0.09%19:30 EDT

Volume:24.34K

Turnover:1.66M

Market Cap:102.06M

PE:- -

High:68.87

Open:66.43

Low:66.35

Close:65.83

52wk High:74.19

52wk Low:40.17

Shares:1.48M

Float Shares:1.48M

Volume Ratio:0.38

T/O Rate:1.64%

Dividend:0.65

Dividend Rate:0.95%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Cboe data shows mixed options sentiment in Moderna with shares down 4.55%

Twist Bioscience on Pace for Record High Close

Natera announces new data shared at ASTRO 2026 on Signatera

Natera Presents New Signatera ctDNA Studies at Astro, Highlighting Radiation Oncology Use Cases

Moderna (MRNA) Names A New COO, Is The Rally Already Priced In?

Simply Wall St.

Moderna COO Juan Andres Files Initial Beneficial Ownership Statement

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Alamar Biosciences Names Former GRAIL CEO Bob Ragusa to Board

Twist Bioscience CEO Emily Leproust Disposes of $8.77 Million in Common Shares

Illumina Inc Stock (ILMN) Moved Up by 7.85% on Oct 5: Drivers Behind the Movement

IntegraGen Faces Judicial Liquidation as Court Weighs Takeover Bids

Moderna Inc Stock (MRNA) Moved Up by 5.71% on Oct 5: What Investors Need To Know

Guardant Health reports COSMOS study published in Cancer Research Communications

Guardant Health Cosmos-MEL01 Study Shows Guardant Reveal Detects 81% of Distant Melanoma Recurrences

Cboe data shows mixed options sentiment in Moderna with shares up 0.52%

Natera, Alliance Foundation Trials Launch Phase III Navigate Breast Cancer Study Using Signatera MRD-Guided Cdk4/6 Therapy

Alliance Foundation Trials and Natera Announce Aft-70 Navigate: a Global, Randomized, Phase Iii Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (Serd) with Signatera™ Mrd-Guided Cdk4/6 Inhibitor Therapy in Breast Cancer

THOMSON REUTERS

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

Gene Editing, Protein Electron Transfer, Self-Assembled Monolayers 鈥?Which Will Win the Nobel Prize in Chemistry? Two Experts Share Their Predictions

Twist Bioscience (TWST) Rallies As Growth Narrative Tests Whether The Stock Is Already Pricey

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/GNOM/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":68.75,"timestamp":1791576000000,"preClose":65.83,"halted":0,"volume":24338,"hourTrading":{"tag":"盘后","latestPrice":68.8111,"preClose":68.75,"latestTime":"19:30 EDT","volume":442,"amount":30399.8128,"timestamp":1791588606681,"change":0.0611,"changeRate":0.000889,"amplitude":0.000889},"delay":0,"changeRate":0.044356676287406985,"floatShares":1484576,"shares":1484576,"eps":0,"marketStatus":"Market Closed","change":2.92,"latestTime":"10-09 16:00:00 EDT","open":66.43,"high":68.87,"low":66.35,"amount":1657764.37312,"amplitude":0.03828,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":65.83,"sharesOutstanding":1094672,"nav":65.87,"aum":97801040.94,"dividendRate":0.009479,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":66,"preClose":65.83,"latestTime":"07:45 EDT","volume":30,"amount":1980,"timestamp":1791546310756,"change":0.17,"changeRate":0.002582,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":68.8111,"preClose":68.75,"latestTime":"19:30 EDT","volume":442,"amount":30399.8128,"timestamp":1791588606681,"change":0.0611,"changeRate":0.000889,"amplitude":0.000889},"volumeRatio":0.37872374834821565,"impliedVol":0.3377,"impliedVolPercentile":0.8486},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1484576,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.37872374834821565,"shares":1484576,"dividePrice":0.6517,"high":68.87,"amplitude":0.03828,"preClose":65.83,"low":66.35,"week52Low":40.17,"pbRate":"--","week52High":74.191,"institutionHeld":0,"latestPrice":68.75,"eps":0,"divideRate":0.009479,"volume":24338,"delay":0,"ttmEps":0,"open":66.43,"prevYearClose":45.4562,"prevWeekClose":69.621,"prevMonthClose":70.48,"prevQuarterClose":70.48,"fiveDayClose":69.621,"twentyDayClose":62.2188,"sixtyDayClose":55.1038},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673057371","title":"Cboe data shows mixed options sentiment in Moderna with shares down 4.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673057371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673057371?lang=en_us&edition=fundamental","pubTime":"2026-10-06 23:20","pubTimestamp":1791300012,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Moderna (MRNA), with shares down $9.25 near $193.96. Options volume running well above average with 84k ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-down-4-55-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-down-4-55-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","BK4534","BK4585","BK4588","BK4568","IDNA","MRNA","MRNX","WDNA","BK4548","BK4501","BK4532","BK4139","BK4533","BK4551","LGHT","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673541510","title":"Twist Bioscience on Pace for Record High Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2673541510","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673541510?lang=en_us&edition=fundamental","pubTime":"2026-10-06 22:05","pubTimestamp":1791295500,"startTime":"0","endTime":"0","summary":"Twist Bioscience Corp.  is currently at $208.58, up $3.58 or 1.75%--Would be new all-time closing high --Would be first record closing high since Jan. 20, 2021, when it closed at $207.97--On pace for largest percent increase since Oct. 5, 2026, when it rose 8.66%--Currently up five of the past six days--Currently up three consecutive days; up 10.92% over this period--Best three day stretch since the three days ending Sept. 28, 2026, when it rose 13.31%--Up 557.57% year-to-date; on pace for best year since 2020, when it rose 572.81%--Up 570.24% from 52 weeks ago , when it closed at $31.12--Would be a new 52-week closing high--Up 719.57% from its 52-week closing low of $25.45 on Nov. 19, 2025--Traded as high as $219.71; new all-time intraday high --Up 7.18% at today's intraday highAll data as of 10:00:39 AM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","IDNA","WDNA","BK4585","BK4139","TWST","BK4588","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673056732","title":"Natera announces new data shared at ASTRO 2026 on Signatera","url":"https://stock-news.laohu8.com/highlight/detail?id=2673056732","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673056732?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:11","pubTimestamp":1791288669,"startTime":"0","endTime":"0","summary":"Natera (NTRA) announced new data recently shared at the American Society for Radiation Oncology, ASTRO, 2026 Annual Meeting. The presentations mark...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/natera-announces-new-data-shared-at-astro-2026-on-signatera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/natera-announces-new-data-shared-at-astro-2026-on-signatera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1988902786.USD","LU2065169927.USD","LU2264538146.SGD","LU0053671581.USD","LU0012050646.USD","LU2065171311.SGD","HELX","LU0963586101.USD","GNOM","LU2324357040.USD","LU0345770308.USD","BK4139","LU0106261612.USD","LU2065170008.USD","LU1064131342.USD","LU0345770993.USD","LU2065171402.SGD","NTRA","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673056597","title":"Natera Presents New Signatera ctDNA Studies at Astro, Highlighting Radiation Oncology Use Cases","url":"https://stock-news.laohu8.com/highlight/detail?id=2673056597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673056597?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:03","pubTimestamp":1791288234,"startTime":"0","endTime":"0","summary":"Natera presents new Signatera ctDNA studies at ASTRO, highlighting radiation oncology use casesNatera reported new Signatera clinical data already presented at the ASTRO 2026 annual meeting, its first","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDLb3spFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","LU0963586101.USD","LU2264538146.SGD","LU2324357040.USD","NTRA","LU0345770308.USD","GNOM","LU0106261612.USD","LU0012050646.USD","LU0345770993.USD","LU2065170008.USD","LU0053671581.USD","LU2065171402.SGD","HELX","LU1988902786.USD","LU2065171311.SGD","LU2065731478.USD","BK4139","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673035352","title":"Moderna (MRNA) Names A New COO, Is The Rally Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673035352","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673035352?lang=en_us&edition=fundamental","pubTime":"2026-10-06 10:20","pubTimestamp":1791253244,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has put a fresh spotlight on its operations after appointing veteran executive Juan Andres as Chief Operating Officer, just as it prepares for the potential commercialization of intismeran autogene and expands its oncology pipeline.\nRecent moves in Moderna’s share price suggest momentum has been building, with a 1-day share price return of 6.95%, a 30-day share price return of 39.62% and a 90-day share price return of 175.35%. The 1-year total shareholder return is very large...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/128680956-card/1789197794273","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/128680956-card/1789197794273"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/moderna-mrna-names-a-new-coo-is-the-rally-already-priced-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/moderna-mrna-names-a-new-coo-is-the-rally-already-priced-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IDNA","GNOM","LGHT","BK4534","WDNA","BK4585","MRNX","BK4588","BK4548","BK4139","BK4533","MRNA","BK4551","MRNY","BK4501","BK4532","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673108789","title":"Moderna COO Juan Andres Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2673108789","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673108789?lang=en_us&edition=fundamental","pubTime":"2026-10-06 06:27","pubTimestamp":1791239256,"startTime":"0","endTime":"0","summary":"Moderna COO Juan Andres files initial beneficial ownership statementModerna COO Juan Andres reported direct ownership of 125,000 common shares in an initial Form 3 filing dated 10/05/2026.Disclaimer:T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLbbQwhM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4548","LGHT","IDNA","WDNA","BK4501","MRNY","BK4551","BK4585","BK4139","BK4534","BK4532","BK4568","BK4533","MRNX","BK4588","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084939","title":"Moderna Inc. Stock Rises 6.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084939","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084939?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:33","pubTimestamp":1791232380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 6.9% to $203.21 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.This was the stock's second consecutive day of gains.Moderna Inc. closed 2.7% below its 52-week high of $208.90, which the company reached on September 29th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.2% to $252.93, Pfizer Inc. fell 1.4% to $27.41, and Gilead Sciences Inc. fell 0.08% to $144.63.Trading volume totaled 18.8 million, compared to the 50-day average of 20.1 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1934455277.USD","BK4578","LU1061106388.HKD","LGHT","LU1674673691.USD","IDNA","BIB","SG9999015952.SGD","MRNX","TMED","BK4583","LU0965509010.AUD","BK4568","IE00B7SZLL34.SGD","BBH","LU0109394709.USD","LU1057294990.SGD","BK4566","MEDI","LU0823416689.USD","LU2324357040.USD","LU0965509101.SGD","IE00B19Z3B42.SGD","WDNA","LU2357627491.SGD","LU0861579265.USD","IE00BZ1G4Q59.USD","LU1839511570.USD","GILD","BK4585","LU0234570918.USD","LU1066051498.USD","IBB","BMED","MRNY","GNOM","BK4533","SG9999015945.SGD","BK4139","TBXU","BK4551","LU2112291526.USD","BK4588","LU1778281490.HKD","MRNA","IBBQ","LU1037948897.HKD","LU2087621335.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081297","title":"Alamar Biosciences Names Former GRAIL CEO Bob Ragusa to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081297","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081297?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:06","pubTimestamp":1791230818,"startTime":"0","endTime":"0","summary":"Alamar Biosciences names former GRAIL CEO Bob Ragusa to boardAlamar Biosciences appointed former GRAIL CEO Bob Ragusa to its board of directors.Ragusa brings more than two decades in genomics, diagnos","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLpj34f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1121112475.USD","LU0348723411.USD","NDAQ","OM","LU0225771236.USD","LU0823417653.USD","ILMN","IE00B64PRP62.GBP","HPE","SG9999014039.USD","LU2210150020.SGD","LU0985481810.HKD","SG9999014021.USD","LU2506951958.HKD","IE00BN0W2V16.EUR","LU2506952097.USD","LU0128526141.USD","LU0994945656.USD","BK4121","LU0823417737.USD","HPEL","IE00BKPKM429.USD","BK4534","IE00BQXX3C00.GBP","SG9999014005.SGD","BK4548","VRSN","LU0234570918.USD","SG9999014013.SGD","GNMX","BK4515","LU1043141396.HKD","IE00B3QW5Z07.USD","BK4116","LU0426417589.USD","LU2210149790.SGD","BK4170","BK4559","LU0321505868.SGD","BK4112","LU2095319765.USD","BK4535","BK4588","IE00BN0W2W23.USD","ALMR","BK4585","LU0306807586.USD","GNOM","BCDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081264","title":"Twist Bioscience CEO Emily Leproust Disposes of $8.77 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081264","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081264?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:06","pubTimestamp":1791230788,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO Emily Leproust disposes of $8.77 million in common sharesTwist Bioscience CEO Emily M. Leproust sold 46,391 common shares on Oct. 1-2.Sales priced at USD 200 and USD 188.884 per s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL57CwR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience CEO Emily Leproust Disposes of $8.77 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","TWST","WDNA","BK4585","BK4139","IDNA","GNOM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089033","title":"Illumina Inc Stock (ILMN) Moved Up by 7.85% on Oct 5: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089033","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089033?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:15","pubTimestamp":1791227742,"startTime":"0","endTime":"0","summary":"• Illumina surged due to significant price target increases from Wall Street firms.  \n• Strong NovaSeq X placement velocity drove durable fundamental momentum and margin improvements.  \n• Technical indicators show a MACD buy signal and an overbought Williams %R.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262200685-market-movers-ilmn-20261005","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4534","BK4588","GNMX","ILMN","LU0029874061.USD","BK4585","GNOM","BK4121","BK4535","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673086069","title":"IntegraGen Faces Judicial Liquidation as Court Weighs Takeover Bids","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086069?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:38","pubTimestamp":1791221905,"startTime":"0","endTime":"0","summary":"IntegraGen SA ( ($FR:ALINT) ) has shared an update. IntegraGen, the French genomics specialist in cancer and rare genetic diseases, is a major prov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/integragen-faces-judicial-liquidation-as-court-weighs-takeover-bids?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/integragen-faces-judicial-liquidation-as-court-weighs-takeover-bids?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","FWD","GNMX","BMED","IDNA","TARK","DARP","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089818","title":"Moderna Inc Stock (MRNA) Moved Up by 5.71% on Oct 5: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089818","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089818?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:15","pubTimestamp":1791220527,"startTime":"0","endTime":"0","summary":"• Moderna joins the Nasdaq-100 Index, driving institutional portfolio rebalancing and share accumulation.\n• Optimism for the Merck partnershiped oncology pipeline boosts long-term investor market sentiment.\n• The company reported an annual revenue of $1.94B and net profit of $-2.82B.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262200511-market-movers-mrna-20261005","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","MRNA","BK4568","BK4139","BK4588","MRNX","BK4501","BK4534","IDNA","LGHT","BK4548","BK4532","BK4551","GNOM","WDNA","MRNY","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085570","title":"Guardant Health reports COSMOS study published in Cancer Research Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085570","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085570?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:30","pubTimestamp":1791214209,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced Cancer Research Communications, a journal of the American Association for Cancer Research, has published results fro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-reports-cosmos-study-published-in-cancer-research-communications-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-reports-cosmos-study-published-in-cancer-research-communications-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","FFOX","LU0889565916.HKD","LU0320765992.SGD","GNMX","PTH","GH","BK4196","EKG","BK4551","BK4535","LU0109394709.USD","GDOC","BK4588","HELX","BK4585","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085807","title":"Guardant Health Cosmos-MEL01 Study Shows Guardant Reveal Detects 81% of Distant Melanoma Recurrences","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085807","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085807?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:27","pubTimestamp":1791214069,"startTime":"0","endTime":"0","summary":"Guardant Health COSMOS-MEL01 study shows Guardant Reveal detects 81% of distant melanoma recurrencesGuardant Health disclosed published results from a prospective, multicenter COSMOS study evaluating ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL5cqdWm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4588","LFSC","GNMX","BK4551","LU0320765992.SGD","PTH","BK4535","HELX","BK4585","EKG","GH","FFOX","GNOM","GDOC","LU0889565916.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673108356","title":"Cboe data shows mixed options sentiment in Moderna with shares up 0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673108356","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673108356?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:35","pubTimestamp":1791210909,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Moderna (MRNA), with shares up 99c, or 0.52%, near $191.00. Options volume relatively light with 15k con...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-up-0-52-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-up-0-52-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","BK4585","BK4139","BK4551","GNOM","MRNY","BK4532","BK4588","WDNA","LGHT","MRNA","MRNX","BK4548","BK4534","BK4501","BK4568","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673024077","title":"Natera, Alliance Foundation Trials Launch Phase III Navigate Breast Cancer Study Using Signatera MRD-Guided Cdk4/6 Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2673024077","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673024077?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:08","pubTimestamp":1791202097,"startTime":"0","endTime":"0","summary":"Natera, Alliance Foundation Trials launch Phase III NAVIGATE breast cancer study using Signatera MRD-guided CDK4/6 therapyNatera joined Alliance Foundation Trials, Genentech to launch AFT-70 NAVIGATE,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL69ccGs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU2065170008.USD","LU1064131342.USD","LU2264538146.SGD","NTRA","LU0053671581.USD","LU2065171311.SGD","LU0012050646.USD","LU0106261612.USD","LU2065169927.USD","LU2065731478.USD","LU0345770308.USD","BK4139","LU2065171402.SGD","HELX","LU0345770993.USD","LU0963586101.USD","LU1988902786.USD","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702177","title":"Alliance Foundation Trials and Natera Announce Aft-70 Navigate: a Global, Randomized, Phase Iii Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (Serd) with Signatera™ Mrd-Guided Cdk4/6 Inhibitor Therapy in Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702177?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:04","pubTimestamp":1791201858,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45Q02E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171311.SGD","LU0012050646.USD","LU0963586101.USD","NTRA","LU2065170008.USD","LU2065169927.USD","LU1988902786.USD","GNOM","LU1064131342.USD","LU2065731478.USD","LU0053671581.USD","HELX","LU0345770308.USD","LU2264538146.SGD","LU2065171402.SGD","LU2324357040.USD","LU0106261612.USD","LU0345770993.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702771","title":"Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702771","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702771?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:00","pubTimestamp":1791201600,"startTime":"0","endTime":"0","summary":"Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374474/18623/en/marea-therapeutics-a-subsidiary-of-lisata-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-mar002-a-potential-best-in-disease-investigational-therapy-for-the.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","KBWY","BK4218","BK4585","BK4007","GH","ENDO","HELX","GNMX","GDOC","BK4183","LFSC","BK4196","FFOX","LENZ","LU0109394709.USD","PTH","LU0889565916.HKD","BK4535","BK4139","EKG","BK4588","PK","BK4181","BK4539","GNOM","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146086402","title":"Gene Editing, Protein Electron Transfer, Self-Assembled Monolayers 鈥?Which Will Win the Nobel Prize in Chemistry? Two Experts Share Their Predictions","url":"https://stock-news.laohu8.com/highlight/detail?id=1146086402","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146086402?lang=en_us&edition=fundamental","pubTime":"2026-10-04 14:50","pubTimestamp":1791096641,"startTime":"0","endTime":"0","summary":"The 2026 Nobel Prize in Chemistry will be announced on the evening of October 7, Beijing time.The Clarivate Citation Laureates list, compiled by the analytics firm Clarivate, honors researchers with...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARK","NBDS","XT","GNOM","BMED","HELX","IDNA","DTEC","FWD","KOMP","WDNA","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672172932","title":"Twist Bioscience (TWST) Rallies As Growth Narrative Tests Whether The Stock Is Already Pricey","url":"https://stock-news.laohu8.com/highlight/detail?id=2672172932","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672172932?lang=en_us&edition=fundamental","pubTime":"2026-10-04 01:21","pubTimestamp":1791048067,"startTime":"0","endTime":"0","summary":"Twist Bioscience (TWST) has drawn fresh attention after recent trading left the stock at US$188.67, with moves over the past month and past 3 months sharply outpacing its shorter term performance.\nFor context, Twist Bioscience now trades at US$188.67 after a 30 day share price return of 44.02% and a 90 day gain of 90.11%. The total shareholder return over the past year is about 6x and over the past three years is close to 10x, which points to strong momentum and a material reset in how the...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/twist-bioscience-twst-rallies-as-growth-narrative-tests-whet","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/twist-bioscience-twst-rallies-as-growth-narrative-tests-whet","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK4588","TWST","GNOM","BK4585","BK4139","WDNA","IDNA","ARKG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}